Last 47 quarters of trend data · Healthcare · Drug Manufacturers - Specialty & Generic
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
Cronos Group Inc.'s quarterly P/E stands at 17.7x, down 38.3% year-over-year — suggesting improving earnings relative to price.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -110.61 | 17.68 | — | 10.37 | — | 28.64 | 4.59 | 25.35 | — | — | — | — | — |
| — | -38.3% | — | -59.1% | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 5.24 | 5.42 | 2.77 | 7.37 | 5.50 | 5.43 | 6.44 | 6.17 | 8.02 | 9.84 | 8.33 | 7.68 | 9.86 |
| — | -0.1% | -56.9% | +19.5% | -31.4% | -44.9% | -22.6% | -19.7% | -18.7% | +3.9% | -20.7% | -18.8% | +3.5% | |
| P/B Ratio | 0.91 | 0.86 | 0.89 | 0.95 | 0.65 | 0.63 | 0.70 | 0.75 | 0.84 | 0.93 | 0.73 | 0.50 | 0.50 |
| — | +36.5% | +26.2% | +26.6% | -22.8% | -32.3% | -3.3% | +48.7% | +69.2% | +41.6% | -13.8% | -22.5% | -22.3% | |
| P/FCF | 6679.09 | 27.17 | 25.66 | 30.71 | — | — | 48.65 | 41.87 | 268.85 | — | 13.26 | — | — |
| — | — | -47.3% | -26.7% | — | — | +267.0% | — | — | — | — | — | — | |
| EV / EBITDA | — | 16.05 | — | 23.83 | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | 2.67 | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Cronos Group Inc.'s operating margin was -3.2% in Q1 2026, down 10.9 pp QoQ and up 9.4 pp YoY.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 32.5% | 41.4% | 17.7% | 50.4% | 43.4% | 42.6% | 35.7% | 10.5% | 22.7% | 17.7% | 8.0% | 16.0% | 16.3% |
| — | -2.7% | -50.3% | +378.7% | +91.1% | +140.1% | +345.9% | -34.1% | +39.2% | +18.1% | +882.4% | +3.9% | -18.6% | |
| Operating Margin | -1.5% | -3.2% | 7.6% | -1.4% | -15.9% | -12.6% | -37.5% | -98.2% | -56.1% | -63.1% | -90.5% | -87.8% | -108.4% |
| — | +74.5% | +120.4% | +98.6% | +71.6% | +80.0% | +58.5% | -11.9% | +48.3% | +40.8% | +43.4% | +34.5% | +7.4% | |
| Net Margin | -4.9% | 30.4% | -2.0% | 71.4% | -118.7% | 19.0% | 144.3% | 24.4% | -31.5% | -8.9% | -187.3% | -6.6% | -44.0% |
| — | +60.3% | -101.4% | +193.2% | -276.3% | +314.1% | +177.1% | +467.7% | +28.2% | +91.0% | +45.6% | +96.3% | +53.0% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -0.8% | 1.2% | -0.2% | 2.3% | -3.5% | 0.6% | 3.9% | 0.8% | -0.8% | -0.2% | -3.4% | -0.1% | -0.6% |
| — | +117.2% | -104.1% | +200.6% | -330.0% | +366.3% | +213.8% | +801.7% | -29.5% | +87.8% | +39.4% | +96.5% | +59.7% | |
| ROA | -0.8% | 1.1% | -0.2% | 2.2% | -3.4% | 0.5% | 3.7% | 0.7% | -0.8% | -0.2% | -3.3% | -0.1% | -0.6% |
| — | +116.6% | -104.1% | +200.6% | -328.3% | +364.8% | +212.3% | +794.3% | -28.9% | +87.7% | +38.6% | +96.5% | +59.3% | |
| ROIC | -0.7% | -0.3% | 1.5% | -0.1% | -1.2% | -1.1% | -3.2% | -10.5% | -5.4% | -3.7% | -2.8% | -1.9% | -1.8% |
| — | +69.3% | +145.9% | +99.0% | +77.6% | +71.1% | -17.3% | -450.3% | -195.9% | -29.7% | +41.5% | +51.8% | +53.5% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Cronos Group Inc.'s Debt/EBITDA ratio is 0.6x — comfortably within a safe range. The current ratio has weakened 21.3% YoY to 21.87x, tightening the short-term liquidity position.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | -28.4% | -27.3% | -6.0% | -5.8% | -22.7% | -22.0% | -32.4% | -33.4% | -32.7% | -31.4% | -58.2% | -59.1% | |
| Debt / EBITDA | — | 0.59 | — | 0.58 | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 19.59 | 21.87 | 19.59 | 22.45 | 24.65 | 27.80 | 18.84 | 24.24 | 28.29 | 28.19 | 22.54 | 30.03 | 33.12 |
| — | -21.3% | +4.0% | -7.4% | -12.9% | -1.4% | -16.5% | -19.3% | -14.6% | -10.3% | +59.9% | +18.4% | +26.5% | |
| Quick Ratio | 18.62 | 20.73 | 18.62 | 21.28 | 23.53 | 26.75 | 18.17 | 23.05 | 27.41 | 27.28 | 21.81 | 28.86 | 31.50 |
| — | -22.5% | +2.5% | -7.7% | -14.2% | -1.9% | -16.7% | -20.1% | -13.0% | -8.9% | +61.0% | +17.9% | +25.2% | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying CRON stock.
Cronos Group Inc.'s current P/E is -110.6x. The average P/E over the last 2 quarters is 14.0x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Cronos Group Inc.'s current operating margin is -1.5%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Cronos Group Inc.'s business trajectory between earnings reports.